BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24185433)

  • 1. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perceptions of a pharmacist-managed weight management clinic in a community setting.
    O'Neal KS; Crosby KM
    Res Social Adm Pharm; 2013; 9(1):129-36. PubMed ID: 22695218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risky drinking among community pharmacy customers in New Zealand and their attitudes towards pharmacist screening and brief interventions.
    Sheridan J; Stewart J; Smart R; McCormick R
    Drug Alcohol Rev; 2012 Jan; 31(1):56-63. PubMed ID: 21463372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies.
    Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
    Int J Clin Pharm; 2018 Apr; 40(2):458-463. PubMed ID: 29442280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-provided rapid HIV testing in two community pharmacies.
    Darin KM; Klepser ME; Klepser DE; Klepser SA; Reeves A; Young M; Scarsi KK
    J Am Pharm Assoc (2003); 2015; 55(1):81-8. PubMed ID: 25415222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists as health educators and risk communicators in the early detection of prostate cancer.
    Odedina FT; Warrick C; Vilme H; Young S
    Res Social Adm Pharm; 2008 Mar; 4(1):59-66. PubMed ID: 18342823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' willingness to pay for cognitive pharmacist services in community pharmacies.
    Lakić D; Stević I; Odalović M; Vezmar-Kovačević S; Tadić I
    Croat Med J; 2017 Oct; 58(5):364-371. PubMed ID: 29094815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
    Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
    Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program.
    Um IS; Krass I; Armour C; Gill T; Chaar BB
    Int J Clin Pharm; 2015 Oct; 37(5):822-33. PubMed ID: 25920908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient awareness of specialized diabetes services provided in community pharmacies.
    Mansell K; Perepelkin J
    Res Social Adm Pharm; 2011 Dec; 7(4):396-405. PubMed ID: 21272537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
    Wilson CG; Park I; Sutherland SE; Ray L
    J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needs assessment study for community pharmacy travel medicine services.
    Hind CA; Bond CM; Lee AJ; van Teijlingen ER
    J Travel Med; 2008; 15(5):328-34. PubMed ID: 19006506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient request for pharmacist counseling and satisfaction: Automated prescription delivery system versus regular pick-up counter.
    Hirsch JD; Oen A; Robertson S; Nguyen N; Daniels C
    J Am Pharm Assoc (2003); 2009; 49(1):73-7. PubMed ID: 19196601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' needs and interests in a self-pay medication therapy management service.
    Friedrich M; Zgarrick D; Masood A; Montuoro J
    J Am Pharm Assoc (2003); 2010; 50(1):72-7. PubMed ID: 20097642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study.
    Doucette WR; Kreling DH; Schommer JC; Gaither CA; Mott DA; Pedersen CA
    J Am Pharm Assoc (2003); 2006; 46(3):348-55. PubMed ID: 16739756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.